✦ LIBER ✦

Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine

✍ Scribed by Jingwei Yu, Jing Gao, Zhihao Lu, Yilin Li, Lin Shen

Book ID: 118821678
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 219 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-012-0292-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphism of TS 3′-UTR predicts survi

Polymorphism of TS 3′-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel

✍ J. Gao, Q. He, D. Hua, Y. Mao, Y. Li, L. Shen 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 251 KB

A multi-center phase II study of S-1 plu

A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer

✍ Jae Jin Lee; Si-Young Kim; Hyun-Cheol Chung; Kyung-Hee Lee; Hong-Suk Song; Won-K 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 355 KB

Weekly nab-Paclitaxel in Combination Wit

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial

✍ Socinski, M. A.; Bondarenko, I.; Karaseva, N. A.; Makhson, A. M.; Vynnychenko, I 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 207 KB